Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
<p>Differential expression analysis gene list of FACS sorted CD16+ compared to CD16- macrophages from human melanoma dissociates.</p>
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , , , , , , , , , , , , , , , , , , |
| 出版: |
2025
|
| 主题: | |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
| _version_ | 1849927633650843648 |
|---|---|
| author | Hansol Lee (15054787) |
| author2 | Angela L. Ferguson (15050051) Camelia Quek (15049218) Ismael A. Vergara (15054784) Ines Pires daSilva (15056800) Ruth Allen (15056803) Tuba Nur Gide (15056806) Jordan W. Conway (15056809) Lambros T. Koufariotis (15056812) Nicholas K. Hayward (14956488) Nicola Waddell (12694196) Matteo S. Carlino (15056815) Alexander M. Menzies (11420816) Robyn P.M. Saw (15056818) Elena Shklovskaya (15056821) Helen Rizos (15008946) Serigne Lo (15056824) Richard A. Scolyer (10778711) Georgina V. Long (11420813) Umaimainthan Palendira (15050084) James S. Wilmott (15008931) |
| author2_role | author author author author author author author author author author author author author author author author author author author author |
| author_facet | Hansol Lee (15054787) Angela L. Ferguson (15050051) Camelia Quek (15049218) Ismael A. Vergara (15054784) Ines Pires daSilva (15056800) Ruth Allen (15056803) Tuba Nur Gide (15056806) Jordan W. Conway (15056809) Lambros T. Koufariotis (15056812) Nicholas K. Hayward (14956488) Nicola Waddell (12694196) Matteo S. Carlino (15056815) Alexander M. Menzies (11420816) Robyn P.M. Saw (15056818) Elena Shklovskaya (15056821) Helen Rizos (15008946) Serigne Lo (15056824) Richard A. Scolyer (10778711) Georgina V. Long (11420813) Umaimainthan Palendira (15050084) James S. Wilmott (15008931) |
| author_role | author |
| dc.creator.none.fl_str_mv | Hansol Lee (15054787) Angela L. Ferguson (15050051) Camelia Quek (15049218) Ismael A. Vergara (15054784) Ines Pires daSilva (15056800) Ruth Allen (15056803) Tuba Nur Gide (15056806) Jordan W. Conway (15056809) Lambros T. Koufariotis (15056812) Nicholas K. Hayward (14956488) Nicola Waddell (12694196) Matteo S. Carlino (15056815) Alexander M. Menzies (11420816) Robyn P.M. Saw (15056818) Elena Shklovskaya (15056821) Helen Rizos (15008946) Serigne Lo (15056824) Richard A. Scolyer (10778711) Georgina V. Long (11420813) Umaimainthan Palendira (15050084) James S. Wilmott (15008931) |
| dc.date.none.fl_str_mv | 2025-11-25T13:03:33Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707056 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Intratumoral_CD16_sup_sup_Macrophages_Are_Associated_with_Clinical_Outcomes_of_Patients_with_Metastatic_Melanoma_Treated_with_Combination_Anti-PD-1_and_Anti-CTLA-4_Therapy/30707056 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers Prognostic biomarkers Immunology Immune responses to cancer Innate immunity Tumor-associated macrophages Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |
| dc.title.none.fl_str_mv | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Differential expression analysis gene list of FACS sorted CD16+ compared to CD16- macrophages from human melanoma dissociates.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_c7c834b28098593ba14f2a0abf645322 |
| identifier_str_mv | 10.1158/1078-0432.30707056 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707056 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 TherapyHansol Lee (15054787)Angela L. Ferguson (15050051)Camelia Quek (15049218)Ismael A. Vergara (15054784)Ines Pires daSilva (15056800)Ruth Allen (15056803)Tuba Nur Gide (15056806)Jordan W. Conway (15056809)Lambros T. Koufariotis (15056812)Nicholas K. Hayward (14956488)Nicola Waddell (12694196)Matteo S. Carlino (15056815)Alexander M. Menzies (11420816)Robyn P.M. Saw (15056818)Elena Shklovskaya (15056821)Helen Rizos (15008946)Serigne Lo (15056824)Richard A. Scolyer (10778711)Georgina V. Long (11420813)Umaimainthan Palendira (15050084)James S. Wilmott (15008931)CancerCancer Detection and DiagnosisImmuno-oncologyBiomarkersPrognostic biomarkersImmunologyImmune responses to cancerInnate immunityTumor-associated macrophagesImmunotherapyBiomarkers for immunotherapyCheckpoint blockadeCombination immunotherapySkin CancersMelanoma<p>Differential expression analysis gene list of FACS sorted CD16+ compared to CD16- macrophages from human melanoma dissociates.</p>2025-11-25T13:03:33ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30707056https://figshare.com/articles/dataset/Supplementary_Table_S3_from_Intratumoral_CD16_sup_sup_Macrophages_Are_Associated_with_Clinical_Outcomes_of_Patients_with_Metastatic_Melanoma_Treated_with_Combination_Anti-PD-1_and_Anti-CTLA-4_Therapy/30707056CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307070562025-11-25T13:03:33Z |
| spellingShingle | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy Hansol Lee (15054787) Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers Prognostic biomarkers Immunology Immune responses to cancer Innate immunity Tumor-associated macrophages Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |
| status_str | publishedVersion |
| title | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_full | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_fullStr | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_full_unstemmed | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_short | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_sort | Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| topic | Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers Prognostic biomarkers Immunology Immune responses to cancer Innate immunity Tumor-associated macrophages Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |